Quality of life for crizotinib vs chemotherapy in Asian ALK-positive NSCLC patients
Blackhall, Fiona H Mok, T Nishio, M Kim, D Wilner, K Reisman, A Iyer, S Solomon, B
Blackhall, Fiona H
Mok, T
Nishio, M
Kim, D
Wilner, K
Reisman, A
Iyer, S
Solomon, B
Citations
Altmetric:
Abstract
Description
Date
2015
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Quality of Life for Crizotinib vs. Chemotherapy in Asian ALK-Positive NSCLC Patients. 2015, 10(9):S378-S379 JTO